EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification

Lukasz Szarpak iD, Monika E Jach iD, Michal Skoczylas, Sebastian Radej iD, Michal Pruc iD

International Journal of Molecular Sciences · 18.03.2026 · 27 (6) · 2750

DOI: 10.3390/ijms27062750 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.03.2026. Verfasst von Lukasz Szarpak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, Collegium Medicum, The John Paul II Catholic University of Lublin, 20-708 Lublin, Poland. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Pulmonary Embolism, Hypertension, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary embolism (PE) is biologically heterogeneous. Despite guideline-directed anticoagulation, a subset of patients develops recurrent venous thromboembolism, persistent exertional limitation, residual perfusion defects, and progression to chronic thromboembolic pulmonary disease (CTEPD) or chronic thromboembolic pulmonary hypertension (CTEPH). Conventional risk factors explain much of the index event but incompletely account for thrombus non-resolution and chronic sequelae. Clonal hematopoiesis of indeterminate potential (CHIP)—the age-associated expansion of hematopoietic clones carrying somatic mutations—defines a measurable thrombo-inflammatory endophenotype that is strongly genotype- and clone-size (variant allele frequency; VAF)-dependent. Across human studies, JAK2-CHIP and TET2-CHIP show the most consistent associations with VTE/PE, whereas isolated DNMT3A-CHIP is frequently neutral, and larger clones tend to confer stronger effects. Mechanistically, CHIP can bias myeloid cells toward inflammasome/IL-1β signaling and endothelial activation, increase monocyte tissue factor activity, and promote immunothrombosis with neutrophil extracellular trap (NET) formation. NET-rich thrombi may adopt a dense fibrin–DNA–histone architecture that resists endogenous fibrinolysis, favoring organization and persistence. CTEPH offers a translational window to interrogate this model because thrombotic material and deep phenotyping are accessible. We synthesize genotype- and VAF-resolved clinical and mechanistic evidence using a structured strength-of-evidence framework and propose a pragmatic phenotyping roadmap with testable predictions for prospective post-PE validation. CHIP testing in PE/CTEPH remains investigational and should not currently change standard care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisPulmonary EmbolismHypertension, PulmonaryHumansDNA Methyltransferase 3AJanus Kinase 2Extracellular TrapsDNA (Cytosine-5-)-MethyltransferasesDNA-Binding ProteinsRisk FactorsAnimalsDioxygenases

Stichwörter der Autor:innen

CHIPCTEPDCTEPHfibrinolysisimmunothrombosisinflammasomeneutrophil extracellular traps (NETs)pulmonary embolismthrombus resolutionvariant allele frequency (VAF)

Substanzen

DNMT3A protein, humanDNA Methyltransferase 3AJanus Kinase 2JAK2 protein, humanTET2 protein, humanDNA (Cytosine-5-)-MethyltransferasesDNA-Binding ProteinsDioxygenases

Autor:innen und Institutionen

  • Institute of Medical Science, Collegium Medicum, The John Paul II Catholic University of Lublin, 20-708 Lublin, Poland.
  • Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • Institute of Biological Sciences, Collegium Medicum, The John Paul II Catholic University of Lublin, 20-708 Lublin, Poland.

ORCID-Profile: Lukasz Szarpak, Monika E Jach, Sebastian Radej, Michal Pruc

Zitieren

APA

Szarpak, L., Jach, M. E., Skoczylas, M., Radej, S., & Pruc, M. (2026). Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification. International Journal of Molecular Sciences, 27(6), 2750. https://doi.org/10.3390/ijms27062750

Vancouver

Szarpak L, Jach ME, Skoczylas M, Radej S, Pruc M. Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification. International Journal of Molecular Sciences. 2026;27(6):2750. doi:10.3390/ijms27062750

BibTeX
@article{Szarpak2026,
  author = {Szarpak, Lukasz and Jach, Monika E and Skoczylas, Michal and Radej, Sebastian and Pruc, Michal},
  title = {Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2750},
  doi = {10.3390/ijms27062750}
}
Kostenlos starten →